PARIS, March 14, 2008 (AFP) - Heart disease, once predominantly the preserve of rich countries, is expanding fast in developing economies, although for rather different reasons, a study carried out in South Africa suggests.
Doctors from South Africa and Australia looked at data from 1,593 people who were diagnosed with cardiovascular disease at the Chris Hani Baragwanath Hospital in Soweto, Johannesburg in 2006.
Eight-five percent of them were black Africans, and 59 percent were women. The patients' average age was in the early to mid-fifties, but a quarter were under 40.
The paper said a large number of patients, especially women, were obese, an established risk factor for heart disease.
Factors specific to South Africa were HIV infection and tuberculosis, which worsen certain kinds of heart disease, along with late diagnosis and a tendency to seek hospital care only after consulting a traditional healer had failed.
The study, which appears in next Saturday's The Lancet, is "relevant to many areas of the world that face similar threats and the emergence of epidemics of heart disease," a commentary in the journal said.
"In some developing countries, such as India, the epidemiological transition has been more rapid and the speed of transition will vary from country to country depending on the exposure time and competing causes."
080314
AF080314
Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. http://www.afp.com/
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.